Literature DB >> 24727297

Psychostimulant addiction treatment.

Karran A Phillips1, David H Epstein2, Kenzie L Preston2.   

Abstract

Treatment of psychostimulant addiction has been a major, and not fully met, challenge. For opioid addiction, there is strong evidence for the effectiveness of several medications. For psychostimulants, there is no corresponding form of agonist maintenance that has met criteria for regulatory approval or generally accepted use. Stimulant-use disorders remain prevalent and can result in both short-term and long-term adverse consequences. The mainstay of treatment remains behavioral interventions. In this paper, we discuss those interventions and some promising candidates in the search for pharmacological interventions. This article is part of the Special Issue entitled 'CNS Stimulants'. Published by Elsevier Ltd.

Entities:  

Keywords:  Addiction; Psychostimulant; Treatment

Mesh:

Substances:

Year:  2014        PMID: 24727297      PMCID: PMC4524548          DOI: 10.1016/j.neuropharm.2014.04.002

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  110 in total

1.  Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up.

Authors:  David H Epstein; Wesley E Hawkins; Lino Covi; Annie Umbricht; Kenzie L Preston
Journal:  Psychol Addict Behav       Date:  2003-03

2.  Influence of acute bupropion pre-treatment on the effects of intranasal cocaine.

Authors:  William W Stoops; Joshua A Lile; Paul E A Glaser; Lon R Hays; Craig R Rush
Journal:  Addiction       Date:  2012-02-11       Impact factor: 6.526

Review 3.  The contribution of impurities to the acute morbidity of illegal drug use.

Authors:  R Shesser; R Jotte; J Olshaker
Journal:  Am J Emerg Med       Date:  1991-07       Impact factor: 2.469

Review 4.  A review of the clinical pharmacology of methamphetamine.

Authors:  Christopher C Cruickshank; Kyle R Dyer
Journal:  Addiction       Date:  2009-04-29       Impact factor: 6.526

Review 5.  Review. The incentive sensitization theory of addiction: some current issues.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

Review 6.  Manual-guided psychosocial treatment. A new virtual requirement for pharmacotherapy trials?

Authors:  K M Carroll
Journal:  Arch Gen Psychiatry       Date:  1997-10

7.  Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone.

Authors:  Chi-Tso Chiu; Tangeng Ma; Ing K Ho
Journal:  Brain Res Bull       Date:  2005-09-30       Impact factor: 4.077

8.  Origin of stimulant use for treatment of attention deficit disorder.

Authors:  M D Gross
Journal:  Am J Psychiatry       Date:  1995-02       Impact factor: 18.112

9.  Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial.

Authors:  T P George; M C Chawarski; J Pakes; K M Carroll; T R Kosten; R S Schottenfeld
Journal:  Biol Psychiatry       Date:  2000-06-15       Impact factor: 13.382

Review 10.  Clinical effects and management of methamphetamine abuse.

Authors:  Frank Romanelli; Kelly M Smith
Journal:  Pharmacotherapy       Date:  2006-08       Impact factor: 4.705

View more
  21 in total

Review 1.  William L. Woolverton: a case history in unraveling the behavioral pharmacology of stimulants.

Authors:  Michael A Nader; Robert L Balster; Jack E Henningfield
Journal:  Neuropharmacology       Date:  2014-05-20       Impact factor: 5.250

2.  An initial randomized controlled trial of behavioral activation for treatment of concurrent crystal methamphetamine dependence and sexual risk for HIV acquisition among men who have sex with men.

Authors:  Matthew J Mimiaga; David W Pantalone; Katie B Biello; Jackie M White Hughto; John Frank; Conall O'Cleirigh; Sari L Reisner; Arjee Restar; Kenneth H Mayer; Steven A Safren
Journal:  AIDS Care       Date:  2019-03-19

3.  Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.

Authors:  Jana Ruda-Kucerova; Zuzana Babinska; Tibor Stark; Vincenzo Micale
Journal:  Neurotox Res       Date:  2017-04-18       Impact factor: 3.911

Review 4.  Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.

Authors:  Chris P Bailey; Stephen M Husbands
Journal:  Expert Opin Drug Discov       Date:  2014-09-25       Impact factor: 6.098

5.  Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Xavier Castells; Lídia Blanco-Silvente; Ruth Cunill
Journal:  Cochrane Database Syst Rev       Date:  2018-08-09

6.  Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial.

Authors:  Richard S Schottenfeld; Marek C Chawarski; Mehmet Sofuoglu; Weng-Tink Chooi; Norzarina M Zaharim; M Azhar M Yasin; Imran Ahmad; Sharifah Zubaidiah Syed Jaapar; B Kasinather Vicknasingam
Journal:  Drug Alcohol Depend       Date:  2018-03-10       Impact factor: 4.492

7.  Risk factors for stimulant use among homeless and unstably housed adult women.

Authors:  Elise D Riley; Martha Shumway; Kelly R Knight; David Guzman; Jennifer Cohen; Sheri D Weiser
Journal:  Drug Alcohol Depend       Date:  2015-05-27       Impact factor: 4.492

Review 8.  Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter.

Authors:  Maarten E A Reith; Bruce E Blough; Weimin C Hong; Kymry T Jones; Kyle C Schmitt; Michael H Baumann; John S Partilla; Richard B Rothman; Jonathan L Katz
Journal:  Drug Alcohol Depend       Date:  2014-12-18       Impact factor: 4.492

9.  Transcranial Direct Current Stimulation Applied to the Dorsolateral and Ventromedial Prefrontal Cortices in Smokers Modifies Cognitive Circuits Implicated in the Nicotine Withdrawal Syndrome.

Authors:  Sarah Aronson Fischell; Thomas J Ross; Zhi-De Deng; Betty Jo Salmeron; Elliot A Stein
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-01-13

10.  Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.

Authors:  E J Young; A M Blouin; S B Briggs; S E Sillivan; L Lin; M D Cameron; G Rumbaugh; C A Miller
Journal:  Mol Psychiatry       Date:  2015-08-04       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.